Ingevity (NGVT) Common Equity (2015 - 2026)

Ingevity (NGVT) has 12 years of Common Equity data on file, last reported at $38.9 million in Q1 2026.

• On a quarterly basis, Common Equity fell 83.42% year-over-year to $38.9 million in Q1 2026; TTM through Mar 2026 was $38.9 million, a 83.42% decrease from a year earlier, with the FY2025 full-year figure at $29.7 million, down 84.78% from the prior year.
• Common Equity for Q1 2026 stood at $38.9 million, up from $29.7 million in the prior quarter.
• Over the last five years, Common Equity for NGVT reached as high as $725.7 million in Q1 2023 and fell as low as $29.7 million in Q4 2025.
• Historically, Common Equity has averaged $428.7 million across 5 years, with a median of $568.2 million in 2024.
• Across the five-year window, Common Equity advanced 13.38% in 2023 and slumped 84.78% in 2025, its largest moves.
• Year by year, Common Equity stood at $698.3 million in 2022, then dropped by 9.58% to $631.4 million in 2023, then slumped by 69.08% to $195.2 million in 2024, then slumped by 84.78% to $29.7 million in 2025, then jumped by 30.98% to $38.9 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $38.9 million in Q1 2026, $29.7 million in Q4 2025, and $138.1 million in Q3 2025.